| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.86B | +12.9% |
| R&D Expense | $158.7M | +20.1% |
| SG&A Expense | $182.3M | +18.4% |
| Operating Income | $1.53B | +10.4% |
| Pre-tax Income | $1.36B | -0.9% |
| Income Tax | $247.0M | +12.1% |
| Net Income | $1.11B | -3.4% |
| EPS (Basic) | $14.09 | -2.5% |
| EPS (Diluted) | $14.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $409.4M | -11.3% |
| Current Assets | $1.34B | -5.2% |
| Total Assets | $5.45B | -1.3% |
| Current Liabilities | $1.59B | +4.5% |
| Long-term Debt | $4.51B | +0.1% |
| Total Liabilities | $6.39B | +2.0% |
| Stockholders' Equity | -$940.0M | -27.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.50B | +21.5% |
| Capital Expenditures | $33.8M | +48.4% |
| Investing Cash Flow | -$144.3M | +82.4% |
| Financing Cash Flow | -$1.40B | -47.0% |
| Free Cash Flow | $1.47B | +21.0% |
| -2.4% |